CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C02404 | BRD-A99833829 | bethanechol | CHRM2 | Acetylcholine receptor agonist | -- | Details |
C02405 | BRD-A99879977 | BRD-A99879977 | -- | -- | -- | Details |
C02406 | BRD-A99911370 | BRD-A99911370 | -- | -- | -- | Details |
C02407 | BRD-A99939097 | carisoprodol | CYP2C19 | Acetylcholine receptor antagonist | -- | Details |
C02408 | BRD-A99990159 | BRD-A99990159 | -- | -- | -- | Details |
C02409 | BRD-K00007652 | BRD-K00007652 | -- | -- | -- | Details |
C02410 | BRD-K00010082 | BRD-K00010082 | -- | -- | -- | Details |
C02411 | BRD-K00020149 | BRD-K00020149 | -- | -- | -- | Details |
C02412 | BRD-K00028814 | BRD-K00028814 | -- | -- | -- | Details |
C02413 | BRD-K00036326 | BRD-K00036326 | -- | -- | -- | Details |
C02414 | BRD-K00043782 | BRD-K00043782 | -- | -- | -- | Details |
C02415 | BRD-K00046588 | BRD-K00046588 | -- | -- | -- | Details |
C02416 | BRD-K00048155 | BRD-K00048155 | -- | -- | -- | Details |
C02417 | BRD-K00048792 | BRD-K00048792 | -- | -- | -- | Details |
C02418 | BRD-K00057967 | BRD-K00057967 | -- | -- | -- | Details |
C02419 | BRD-K00059671 | BRD-K00059671 | -- | -- | -- | Details |
C02420 | BRD-K00061590 | BRD-K00061590 | -- | -- | -- | Details |
C02421 | BRD-K00064877 | BRD-K00064877 | -- | -- | -- | Details |
C02422 | BRD-K00064929 | BRD-K00064929 | -- | -- | -- | Details |
C02423 | BRD-K00069117 | BRD-K00069117 | -- | -- | -- | Details |
C02424 | BRD-K00069709 | BRD-K00069709 | -- | -- | -- | Details |
C02425 | BRD-K00074324 | BRD-K00074324 | -- | -- | -- | Details |
C02426 | BRD-K00077635 | estramustine-phosphate | ESR1; ESR2; MAP1A; MAP2 | DNA inhibitor; DNA alkylating agent; Microtubule inhibitor; DNA synthesis inhibitor; Estrogen receptor agonist | -- | Details |
C02427 | BRD-K00078503 | BRD-K00078503 | -- | -- | -- | Details |
C02428 | BRD-K00081911 | BRD-K00081911 | -- | -- | -- | Details |
C02429 | BRD-K00083176 | BRD-K00083176 | -- | -- | -- | Details |
C02430 | BRD-K00083518 | BRD-K00083518 | -- | -- | -- | Details |
C02431 | BRD-K00086692 | BRD-K00086692 | -- | -- | -- | Details |
C02432 | BRD-K00088062 | cyanoquinoline-11 | -- | -- | CYANOQUINOLINE-11 | Details |
C02433 | BRD-K00113100 | BRD-K00113100 | -- | -- | -- | Details |
C02434 | BRD-K00117639 | BRD-K00117639 | -- | -- | -- | Details |
C02435 | BRD-K00119817 | BRD-K00119817 | -- | -- | -- | Details |
C02436 | BRD-K00124439 | BRD-K00124439 | -- | -- | -- | Details |
C02437 | BRD-K00133896 | BRD-K00133896 | -- | -- | -- | Details |
C02438 | BRD-K00137579 | BRD-K00137579 | -- | -- | -- | Details |
C02439 | BRD-K00141480 | tanshinone-iia | IL1B; TNF; NR1I2 | Interleukin inhibitor; Anti-inflammatory agent | -- | Details |
C02440 | BRD-K00141503 | BRD-K00141503 | -- | -- | -- | Details |
C02441 | BRD-K00144236 | BRD-K00144236 | -- | -- | -- | Details |
C02442 | BRD-K00150267 | BRD-K00150267 | -- | -- | -- | Details |
C02443 | BRD-K00152668 | adarotene | RARB; RARG | Retinoid receptor agonist | -- | Details |
C02444 | BRD-K00172657 | BRD-K00172657 | -- | -- | -- | Details |
C02445 | BRD-K00175211 | BRD-K00175211 | -- | -- | -- | Details |
C02446 | BRD-K00177096 | BRD-K00177096 | -- | -- | -- | Details |
C02447 | BRD-K00179355 | BRD-K00179355 | -- | -- | -- | Details |
C02448 | BRD-K00183357 | BRD-K00183357 | -- | -- | -- | Details |
C02449 | BRD-K00184207 | GR-206 | -- | -- | -- | Details |
C02450 | BRD-K00185670 | BRD-K00185670 | -- | -- | -- | Details |
C02451 | BRD-K00188019 | BRD-K00188019 | -- | -- | -- | Details |
C02452 | BRD-K00191683 | BRD-K00191683 | -- | -- | -- | Details |
C02453 | BRD-K00196194 | BRD-K00196194 | -- | -- | -- | Details |
C02454 | BRD-K00198051 | BRD-K00198051 | -- | -- | zuclopenthixol | Details |
C02455 | BRD-K00199388 | BRD-K00199388 | -- | -- | -- | Details |
C02456 | BRD-K00199686 | BRD-K00199686 | -- | -- | -- | Details |
C02457 | BRD-K00203625 | BRD-K00203625 | -- | -- | -- | Details |
C02458 | BRD-K00206590 | P-1075 | KCNJ11 | ATP channel activator; Potassium channel activator | -- | Details |
C02459 | BRD-K00209945 | BRD-K00209945 | -- | -- | -- | Details |
C02460 | BRD-K00218068 | BRD-K00218068 | -- | -- | -- | Details |
C02461 | BRD-K00223956 | BRD-K00223956 | -- | -- | -- | Details |
C02462 | BRD-K00224166 | BRD-K00224166 | -- | -- | -- | Details |
C02463 | BRD-K00231307 | BRD-K00231307 | -- | -- | -- | Details |
C02464 | BRD-K00232157 | BRD-K00232157 | -- | -- | -- | Details |
C02465 | BRD-K00233837 | BRD-K00233837 | -- | -- | -- | Details |
C02466 | BRD-K00234327 | RU-24969 | HTR1A; HTR1B; HTR6 | Serotonin receptor agonist | -- | Details |
C02467 | BRD-K00235433 | LG-100754 | -- | -- | -- | Details |
C02468 | BRD-K00241248 | BRD-K00241248 | -- | -- | -- | Details |
C02469 | BRD-K00243272 | BRD-K00243272 | -- | -- | -- | Details |
C02470 | BRD-K00248354 | BRD-K00248354 | -- | -- | -- | Details |
C02471 | BRD-K00248931 | BRD-K00248931 | -- | -- | -- | Details |
C02472 | BRD-K00256256 | AMZ-30 | -- | -- | -- | Details |
C02473 | BRD-K00256608 | BRD-K00256608 | -- | -- | -- | Details |
C02474 | BRD-K00258161 | LJH-685 | -- | -- | -- | Details |
C02475 | BRD-K00259552 | BRD-K00259552 | -- | -- | -- | Details |
C02476 | BRD-K00259736 | colchicine | TUBB; TUBB1 | Microtubule inhibitor | -- | Details |
C02477 | BRD-K00260816 | BRD-K00260816 | -- | -- | -- | Details |
C02478 | BRD-K00262440 | BRD-K00262440 | -- | -- | -- | Details |
C02479 | BRD-K00262667 | BRD-K00262667 | -- | -- | -- | Details |
C02480 | BRD-K00263786 | BRD-K00263786 | -- | -- | -- | Details |
C02481 | BRD-K00265832 | BRD-K00265832 | -- | -- | -- | Details |
C02482 | BRD-K00270349 | BRD-K00270349 | -- | -- | -- | Details |
C02483 | BRD-K00278564 | BRD-K00278564 | -- | -- | -- | Details |
C02484 | BRD-K00280580 | BRD-K00280580 | -- | -- | -- | Details |
C02485 | BRD-K00289828 | BRD-K00289828 | -- | -- | -- | Details |
C02486 | BRD-K00300115 | BRD-K00300115 | -- | -- | -- | Details |
C02487 | BRD-K00303543 | BRD-K00303543 | -- | -- | -- | Details |
C02488 | BRD-K00312224 | PPT | ESR1 | Estrogen receptor agonist | ppt | Details |
C02489 | BRD-K00313977 | BRD-K00313977 | APEX1 | APEX inhibitor | -- | Details |
C02490 | BRD-K00314651 | BRD-K00314651 | -- | -- | -- | Details |
C02491 | BRD-K00317040 | BRD-K00317040 | -- | -- | -- | Details |
C02492 | BRD-K00317371 | RITA | MDM2 | MDM inhibitor | rita | Details |
C02493 | BRD-K00323141 | BRD-K00323141 | -- | -- | -- | Details |
C02494 | BRD-K00328666 | BRD-K00328666 | -- | -- | -- | Details |
C02495 | BRD-K00337317 | NU-7441 | PRKDC | P-glycoprotein inhibitor; DNA dependent protein kinase inhibitor | -- | Details |
C02496 | BRD-K00342680 | BRD-K00342680 | -- | -- | -- | Details |
C02497 | BRD-K00346458 | BRD-K00346458 | -- | -- | -- | Details |
C02498 | BRD-K00347265 | BRD-K00347265 | -- | -- | -- | Details |
C02499 | BRD-K00347903 | BRD-K00347903 | -- | -- | -- | Details |
C02500 | BRD-K00348196 | BRD-K00348196 | -- | -- | -- | Details |
C02501 | BRD-K00349278 | BRD-K00349278 | -- | -- | -- | Details |
C02502 | BRD-K00350773 | BRD-K00350773 | -- | -- | -- | Details |
C02503 | BRD-K00359952 | BRD-K00359952 | -- | -- | -- | Details |